• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组独特的患者源性皮肤鳞状细胞癌细胞系为治疗性测试提供了临床前途径。

A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.

机构信息

Blizard Institute, Barts and the London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.

Barts Cancer Institute, QMUL, London EC1M 6BQ, UK.

出版信息

Int J Mol Sci. 2019 Jul 12;20(14):3428. doi: 10.3390/ijms20143428.

DOI:10.3390/ijms20143428
PMID:31336867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6678499/
Abstract

BACKGROUND

Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with increasing morbidity and mortality, with limited treatment options for advanced disease. Future improvements in targeted therapy will rely on advances in genomic/transcriptomic understanding and the use of model systems for basic research. We describe here the panel of 16 primary and metastatic cSCC cell lines developed and characterised over the past three decades in our laboratory in order to provide such a resource for future preclinical research and drug screening.

METHODS

Primary keratinocytes were isolated from cSCC tumours and metastases, and cell lines were established. These were characterised using short tandem repeat (STR) profiling and genotyped by whole exome sequencing. Multiple in vitro assays were performed to document their morphology, growth characteristics, migration and invasion characteristics, and in vivo xenograft growth.

RESULTS

STR profiles of the cSCC lines allow the confirmation of their unique identity. Phylogenetic trees derived from exome sequence analysis of the matched primary and metastatic lines provide insight into the genetic basis of disease progression. The results of in vivo and in vitro analyses allow researchers to select suitable cell lines for specific experimentation.

CONCLUSIONS

There are few well-characterised cSCC lines available for widespread preclinical experimentation and drug screening. The described cSCC cell line panel provides a critical tool for in vitro and in vivo experimentation.

摘要

背景

皮肤鳞状细胞癌(cSCC)的发病率持续上升,发病率和死亡率不断增加,晚期疾病的治疗选择有限。未来靶向治疗的进展将依赖于基因组/转录组理解的进步和基础研究模型系统的使用。我们在这里描述了过去三十年来在我们实验室中开发和表征的 16 种原发性和转移性 cSCC 细胞系,以便为未来的临床前研究和药物筛选提供这样的资源。

方法

从 cSCC 肿瘤和转移灶中分离原代角质形成细胞,并建立细胞系。这些细胞系通过短串联重复(STR)分析进行特征分析,并通过全外显子组测序进行基因分型。进行了多种体外检测,以记录它们的形态、生长特征、迁移和侵袭特征以及体内异种移植物生长。

结果

cSCC 系的 STR 谱可确认其独特的身份。来自匹配的原发性和转移性系的外显子组序列分析得出的系统发育树提供了疾病进展遗传基础的深入了解。体内和体外分析的结果允许研究人员为特定实验选择合适的细胞系。

结论

可用于广泛的临床前实验和药物筛选的特征良好的 cSCC 系很少。描述的 cSCC 细胞系面板为体外和体内实验提供了重要工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b451c407ab83/ijms-20-03428-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b833bc398807/ijms-20-03428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b966a3b026f9/ijms-20-03428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/e51c08950511/ijms-20-03428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/8d98197b02f6/ijms-20-03428-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/009f1d8311bc/ijms-20-03428-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b451c407ab83/ijms-20-03428-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b833bc398807/ijms-20-03428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b966a3b026f9/ijms-20-03428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/e51c08950511/ijms-20-03428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/8d98197b02f6/ijms-20-03428-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/009f1d8311bc/ijms-20-03428-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235c/6678499/b451c407ab83/ijms-20-03428-g006.jpg

相似文献

1
A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.一组独特的患者源性皮肤鳞状细胞癌细胞系为治疗性测试提供了临床前途径。
Int J Mol Sci. 2019 Jul 12;20(14):3428. doi: 10.3390/ijms20143428.
2
Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.新转移性皮肤鳞状细胞癌细胞系的全面突变和表型特征揭示了新的药物敏感性。
Int J Mol Sci. 2020 Dec 15;21(24):9536. doi: 10.3390/ijms21249536.
3
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.硫酸软骨素蛋白聚糖4通过调节转化生长因子-β信号通路增加隐性营养不良型大疱性表皮松解症相关皮肤鳞状细胞癌的侵袭性。
Br J Dermatol. 2024 Dec 23;192(1):104-117. doi: 10.1093/bjd/ljae295.
4
Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.肿瘤细胞特异性AIM2调节皮肤鳞状细胞癌的生长和侵袭。
Oncotarget. 2017 Jul 11;8(28):45825-45836. doi: 10.18632/oncotarget.17573.
5
Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.依立布林抑制皮肤鳞状细胞癌细胞系和新型患者来源异种移植物的生长。
Sci Rep. 2023 May 27;13(1):8650. doi: 10.1038/s41598-023-35811-3.
6
Clustering of RNA co-expression network identifies novel long non-coding RNA biomarkers in squamous cell carcinoma.RNA 共表达网络聚类鉴定鳞状细胞癌中的新型长非编码 RNA 生物标志物。
Sci Rep. 2024 Jul 23;14(1):16864. doi: 10.1038/s41598-024-67808-x.
7
CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.环状 RNA hsa_circ_0070934 通过海绵吸附 miR-1236-3p 调控 HOXB7 表达,在皮肤鳞状细胞癌中发挥竞争性内源性 RNA 的作用。
Int J Oncol. 2020 Aug;57(2):478-487. doi: 10.3892/ijo.2020.5066. Epub 2020 May 14.
8
Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expression.松油烯-4-醇通过增强钙蛋白酶-2的表达来抑制皮肤鳞状细胞癌细胞的增殖和运动能力。
Oncol Res. 2025 Feb 28;33(3):605-616. doi: 10.32604/or.2024.050661. eCollection 2025.
9
Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.ARMC8 的下调通过激活 Wnt/β-catenin 通路和 EMT 促进皮肤鳞状细胞癌的发生。
J Dermatol Sci. 2021 Jun;102(3):184-192. doi: 10.1016/j.jdermsci.2021.05.002. Epub 2021 May 10.
10
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.miRNA-214 通过 VEGFA 和 Bcl-2 预防皮肤鳞状细胞癌的特征。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980098. doi: 10.1177/1533033820980098.

引用本文的文献

1
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.癌症诱导的神经损伤促进对抗PD-1疗法的耐药性。
Nature. 2025 Aug 20. doi: 10.1038/s41586-025-09370-8.
2
Role of Kindlin-2 in Cutaneous Squamous Carcinoma Cell Migration and Proliferation: Implications for Tumour Progression.Kindlin-2在皮肤鳞状细胞癌细胞迁移和增殖中的作用:对肿瘤进展的影响
Int J Mol Sci. 2025 Aug 1;26(15):7426. doi: 10.3390/ijms26157426.
3
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况

本文引用的文献

1
Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.研究组探究了组蛋白去乙酰化酶抑制剂 MS-275 作为一种局部制剂,在 SKH-1 无毛小鼠模型中预防和治疗皮肤鳞状细胞癌的作用。
PLoS One. 2019 Mar 13;14(3):e0213095. doi: 10.1371/journal.pone.0213095. eCollection 2019.
2
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.英格兰转移性皮肤鳞状细胞癌的全国发病率。
JAMA Dermatol. 2019 Mar 1;155(3):298-306. doi: 10.1001/jamadermatol.2018.4219.
3
The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
4
Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.增强经皮给药:皮肤模型的前沿视角
JID Innov. 2024 Dec 17;5(2):100340. doi: 10.1016/j.xjidi.2024.100340. eCollection 2025 Mar.
5
Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.微小 RNA 在角质细胞癌中的失调:临床证据、功能影响和未来方向。
Int J Mol Sci. 2024 Aug 3;25(15):8493. doi: 10.3390/ijms25158493.
6
The influence of viscosity of hydrogels on the spreading and migration of cells in 3D bioprinted skin cancer models.水凝胶粘度对三维生物打印皮肤癌模型中细胞铺展和迁移的影响。
Front Cell Dev Biol. 2024 May 21;12:1391259. doi: 10.3389/fcell.2024.1391259. eCollection 2024.
7
Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line.建立并鉴定新型侵袭性人皮肤鳞状细胞癌细胞系 HCB-541。
Hum Cell. 2024 Jul;37(4):1170-1183. doi: 10.1007/s13577-024-01054-1. Epub 2024 Apr 3.
8
Mena regulates nesprin-2 to control actin-nuclear lamina associations, trans-nuclear membrane signalling and gene expression.Mena 通过调节核膜蛋白 nesprin-2 来控制肌动蛋白-核层连接、核膜间信号转导和基因表达。
Nat Commun. 2023 Mar 23;14(1):1602. doi: 10.1038/s41467-023-37021-x.
9
A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).一个诱人的靶点?皮肤鳞状细胞癌进展中上皮-间质转化的临床和实验证据(一项范围界定性系统评价)
Discov Oncol. 2022 Jun 6;13(1):42. doi: 10.1007/s12672-022-00510-4.
10
Investigating Cutaneous Squamous Cell Carcinoma and : Novel 3D Tools and Animal Models.皮肤鳞状细胞癌的研究及:新型3D工具和动物模型。 (原标题中“and”后似有缺失内容)
Front Med (Lausanne). 2022 May 9;9:875517. doi: 10.3389/fmed.2022.875517. eCollection 2022.
皮肤鳞状细胞癌的基因组特征揭示了驱动因素和一种新型的巯嘌呤相关突变特征。
Nat Commun. 2018 Sep 10;9(1):3667. doi: 10.1038/s41467-018-06027-1.
4
Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.芦可替尼抑制环孢素诱导的皮肤鳞状细胞癌增殖。
JCI Insight. 2018 Sep 6;3(17). doi: 10.1172/jci.insight.120750.
5
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.西妥昔单抗联合 PD-1 抑制剂治疗晚期皮肤鳞状细胞癌的疗效和安全性
N Engl J Med. 2018 Jul 26;379(4):341-351. doi: 10.1056/NEJMoa1805131. Epub 2018 Jun 4.
6
Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.靶向剪接体用于皮肤鳞状细胞癌治疗:c-MYC和野生型p53在确定肿瘤选择性程度中的作用
Oncotarget. 2018 May 1;9(33):23029-23046. doi: 10.18632/oncotarget.25196.
7
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.蛋白酶体和泛素E1酶抑制剂在皮肤鳞状细胞癌中的临床前比较:鉴别敏感性差异机制
Oncotarget. 2018 Apr 17;9(29):20265-20281. doi: 10.18632/oncotarget.24750.
8
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma.SMAD2/3激活降低独立预测人类皮肤鳞状细胞癌深度增加。
Oncotarget. 2018 Feb 22;9(18):14552-14566. doi: 10.18632/oncotarget.24545. eCollection 2018 Mar 6.
9
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.用双组蛋白去乙酰化酶和去甲基化酶抑制剂靶向CoREST复合物。
Nat Commun. 2018 Jan 4;9(1):53. doi: 10.1038/s41467-017-02242-4.
10
Inactivated Wnt signaling in resveratrol-treated epidermal squamous cancer cells and its biological implication.白藜芦醇处理的表皮鳞状癌细胞中Wnt信号通路的失活及其生物学意义。
Oncol Lett. 2017 Aug;14(2):2239-2243. doi: 10.3892/ol.2017.6458. Epub 2017 Jun 22.